Administered prices, drugs: report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ...
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Washington
US Gov. Print. Off.
1961
|
Schriftenreihe: | Report / United States Congress, Senate
87,1 |
Schlagworte: | |
Beschreibung: | VIII, 374 S. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV026641338 | ||
003 | DE-604 | ||
005 | 20110228 | ||
007 | t | ||
008 | 110326s1961 |||| 10||| eng d | ||
035 | |a (OCoLC)918383243 | ||
035 | |a (DE-599)BVBBV026641338 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-188 | ||
245 | 1 | 0 | |a Administered prices, drugs |b report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... |
264 | 1 | |a Washington |b US Gov. Print. Off. |c 1961 | |
300 | |a VIII, 374 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Report / United States Congress, Senate |v 87,1 | |
650 | 4 | |a Costs and Cost Analysis | |
650 | 4 | |a Drug Industry / economics / United States | |
650 | 4 | |a Drug Industry / economics / United States / legislation | |
650 | 4 | |a Drugs | |
650 | 4 | |a Drug Industry / United States | |
650 | 4 | |a Price Policy | |
651 | 4 | |a USA | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
710 | 2 | |a USA |b Congress |b Senate |b Committee on the Judiciary |b Subcommittee on Antitrust and Monopoly |e Sonstige |0 (DE-588)42831-0 |4 oth | |
810 | 2 | |a United States |p Senate |t Senate reports |v 87,1 |w (DE-604)BV026654897 |9 87,1 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-022192570 |
Datensatz im Suchindex
_version_ | 1804145246645256192 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV026641338 |
ctrlnum | (OCoLC)918383243 (DE-599)BVBBV026641338 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01381nam a2200361 cb4500</leader><controlfield tag="001">BV026641338</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110228 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110326s1961 |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)918383243</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV026641338</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Administered prices, drugs</subfield><subfield code="b">report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington</subfield><subfield code="b">US Gov. Print. Off.</subfield><subfield code="c">1961</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 374 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Report / United States Congress, Senate</subfield><subfield code="v">87,1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Costs and Cost Analysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry / economics / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry / economics / United States / legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Price Policy</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">USA</subfield><subfield code="b">Congress</subfield><subfield code="b">Senate</subfield><subfield code="b">Committee on the Judiciary</subfield><subfield code="b">Subcommittee on Antitrust and Monopoly</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)42831-0</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">United States </subfield><subfield code="p">Senate</subfield><subfield code="t">Senate reports</subfield><subfield code="v">87,1</subfield><subfield code="w">(DE-604)BV026654897</subfield><subfield code="9">87,1</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-022192570</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV026641338 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T23:16:24Z |
institution | BVB |
institution_GND | (DE-588)42831-0 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-022192570 |
oclc_num | 918383243 |
open_access_boolean | |
owner | DE-188 |
owner_facet | DE-188 |
physical | VIII, 374 S. |
publishDate | 1961 |
publishDateSearch | 1961 |
publishDateSort | 1961 |
publisher | US Gov. Print. Off. |
record_format | marc |
series2 | Report / United States Congress, Senate |
spelling | Administered prices, drugs report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... Washington US Gov. Print. Off. 1961 VIII, 374 S. txt rdacontent n rdamedia nc rdacarrier Report / United States Congress, Senate 87,1 Costs and Cost Analysis Drug Industry / economics / United States Drug Industry / economics / United States / legislation Drugs Drug Industry / United States Price Policy USA (DE-588)1071861417 Konferenzschrift gnd-content USA Congress Senate Committee on the Judiciary Subcommittee on Antitrust and Monopoly Sonstige (DE-588)42831-0 oth United States Senate Senate reports 87,1 (DE-604)BV026654897 87,1 |
spellingShingle | Administered prices, drugs report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... Costs and Cost Analysis Drug Industry / economics / United States Drug Industry / economics / United States / legislation Drugs Drug Industry / United States Price Policy |
subject_GND | (DE-588)1071861417 |
title | Administered prices, drugs report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... |
title_auth | Administered prices, drugs report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... |
title_exact_search | Administered prices, drugs report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... |
title_full | Administered prices, drugs report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... |
title_fullStr | Administered prices, drugs report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... |
title_full_unstemmed | Administered prices, drugs report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... |
title_short | Administered prices, drugs |
title_sort | administered prices drugs report of the committee on the judiciary united states senate by its subcommittee on antitrust and monopoly pursuant to s res 52 87 1 congress |
title_sub | report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ... |
topic | Costs and Cost Analysis Drug Industry / economics / United States Drug Industry / economics / United States / legislation Drugs Drug Industry / United States Price Policy |
topic_facet | Costs and Cost Analysis Drug Industry / economics / United States Drug Industry / economics / United States / legislation Drugs Drug Industry / United States Price Policy USA Konferenzschrift |
volume_link | (DE-604)BV026654897 |
work_keys_str_mv | AT usacongresssenatecommitteeonthejudiciarysubcommitteeonantitrustandmonopoly administeredpricesdrugsreportofthecommitteeonthejudiciaryunitedstatessenatebyitssubcommitteeonantitrustandmonopolypursuanttosres52871congress |